We are live on ! Find out more
PLSE icon

Pulse Biosciences
PLSE

49 hedge funds and large institutions have $47.4M invested in Pulse Biosciences in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

433% more capital invested

Capital invested by funds: $8.89M → $47.4M (+$38.5M)

263% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 8

69% more funds holding

Funds holding: 29 → 49 (+20)

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

6.6% more ownership

Funds ownership: 3.08% → 9.69% (+6.6%)

Holders
49
Holders Change
+20
Holders Change %
+68.97%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
9
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$12.1M
2
State Street
State Street
Massachusetts
+$3.61M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.44M
4
Northern Trust
Northern Trust
Illinois
+$2.4M
5
Wells Fargo
Wells Fargo
California
+$1.48M

Top Sellers

Rank Fund Capital Flow
1
CCM
Cadence Capital Management
Massachusetts
-$506K
2
UBS Group
UBS Group
Switzerland
-$455K
3
JAM
JW Asset Management
Florida
-$448K
4
TC
TFS Capital
Pennsylvania
-$286K
5
Millennium Management
Millennium Management
New York
-$244K
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
26
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$250K +$198K +7,210 New
VKH
27
Virtu KCG Holdings
New York
$240K -$85.3K -3,104 -31%
MLICM
28
Metropolitan Life Insurance Company (MetLife)
New York
$233K +$186K +6,760 New
AIG
29
American International Group
New York
$195K +$155K +5,655 New
NFA
30
Nationwide Fund Advisors
Ohio
$177K +$141K +5,126 New
SPIA
31
Steward Partners Investment Advisory
New York
$127K +$101K +3,680 New
SO
32
STRS Ohio
Ohio
$93K +$74.2K +2,700 New
Legal & General Group
33
Legal & General Group
United Kingdom
$83K +$66.4K +2,416 New
Barclays
34
Barclays
United Kingdom
$53K -$98.1K -3,569 -70%
AG
35
Advisor Group
Arizona
$51K +$40.7K +1,482 New
Fifth Third Bancorp
36
Fifth Third Bancorp
Ohio
$35K – – –
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$33K +$26.3K +955 New
AIP
38
Ameritas Investment Partners
Nebraska
$28K +$22K +800 New
Creative Planning
39
Creative Planning
Kansas
$10K -$4.81K -175 -37%
PNC Financial Services Group
40
PNC Financial Services Group
Pennsylvania
$10K – – –
AIM
41
Acrospire Investment Management
Illinois
$8K -$13.2K -479 -68%
LTFS
42
Ladenburg Thalmann Financial Services
Florida
$7K – – –
Federated Hermes
43
Federated Hermes
Pennsylvania
$7K +$5.91K +215 New
JP Morgan Chase
44
JP Morgan Chase
New York
$6K +$4.4K +160 New
Bank of America
45
Bank of America
North Carolina
$3K -$33.3K -1,211 -91%
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$3K +$330 +12 +12%
Citigroup
47
Citigroup
New York
$2K +$1.68K +61 New
SSB
48
Sandy Spring Bank
Maryland
$1K +$412 +15 New
IWM
49
IHT Wealth Management
Illinois
$7 +$3.9K +142 +15%
JAM
50
JW Asset Management
Florida
– -$448K -21,954 Closed
1
2
3

PLSE Hedge Fund Activity: Q2 2017 in Review

49 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q2 2017, worth a combined $47.4M — up 433% from $8.89M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PLSE positions and 8 closed out — a net gain of 21 holders — while 9 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $12.1M. The largest seller was Cadence Capital Management, cutting an estimated $506K.

  • 49 institutional investors held Pulse Biosciences (PLSE) as of Q2 2017, up from 29 in Q1 2017.
  • Funds reported $47.4M of Pulse Biosciences stock for Q2 2017, up 433% quarter-over-quarter.
  • 29 funds opened new Pulse Biosciences positions in Q2 2017 and 8 closed out, a net change of +21 holders.
  • The largest Pulse Biosciences buyer in Q2 2017 was BlackRock, an estimated $12.1M added.
  • The largest Pulse Biosciences seller in Q2 2017 was Cadence Capital Management, an estimated $506K sold.

Based on aggregated 13F filings for Q2 2017.